LoadingLoadingLoading43 funds hold it.Insiders net selling.
Net selling: insiders sold $5.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 21, 2026
Financial period
3Q 2026
Earnings per share
$4.69 expected
Revenue
Company release
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 21, 2026 | $6.99est. $4.69 | +48.89%beat | $50.40BCompany release | -0.6%from $50.71B |
| Jun 30, 2026Reported Jul 15, 2026 | $7.45est. $6.21 | +19.99%beat | $49.80BCompany release | 0.0%from $49.78B |
| Mar 31, 2026Reported Apr 22, 2026 | $12.58est. $10.81 | +16.36%beat | $50.18BSEC filing | +2.6%from $48.89B |
| Dec 31, 2025Reported Jan 28, 2026 | $3.33est. $3.09 | +7.65%beat | $49.75BAlpha Vantage | +9.5%from $45.44B |
| Sep 30, 2025Reported Oct 21, 2025 | $6.03est. $4.94 | +22.06%beat | $50.71BSEC filing | +12.4%from $45.11B |
| Jun 30, 2025Reported Jul 17, 2025 | $8.84est. $8.92 | -0.90%in line | $49.78BSEC filing | +13.4%from $43.89B |
| Mar 31, 2025Reported Apr 22, 2025 | $11.97est. $11.48 | +4.27%beat | $48.89BSEC filing | +14.8%from $42.58B |
| Dec 31, 2024Reported Jan 23, 2025 | $3.84est. $3.85 | -0.26%in line | $45.44BAlpha Vantage | +6.6%from $42.65B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $49.75B | $50.18B | $50.47B | $51.43B |
| Cost of what it sold | $38.06B | $41.08B | $5.49B | $43.42B |
| Gross profit | $11.68B | $9.10B | $44.98B | $8.01B |
| What it spent | ||||
| Sales and admin | — | $6.33B | — | — |
| Other operating costs | $11.10B | $112.0M | $42.92B | $5.86B |
| Total operating expenses | $11.10B | $6.44B | $42.92B | $5.86B |
| What was left | ||||
| Operating profit | $581.0M | $2.66B | $2.06B | $2.15B |
| Interest on debt | $366.0M | $357.0M | $56.0M | $358.0M |
| Profit before tax | $215.0M | $2.30B | $1.94B | $1.79B |
| Tax | -$331.0M | $544.0M | $483.0M | $451.0M |
| Net profit | $547.0M | $1.76B | $1.46B | $1.36B |
| EBITDA | $987.0M | $3.02B | $2.36B | $2.52B |
This stock's price action is mixed.
Trend
Mixed
45 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
A class action lawsuit alleging the Meta pixel illegally collected patient data will move forward.
NeutralNov 4Health insurers, hospitals rally after sweeping midterm win for Democrats
Leans bullishNov 4Elevance Health stock: Wells Fargo lifts target to USD 492
BullishNov 4What UnitedHealth Group Doubters Missed
NeutralNov 4CVS plans to break up $117B healthcare conglomerate
NeutralNov 4CVS Health explores splitting retail pharmacy, insurance businesses, FT reports
Leans bullishNov 3Cardinal Health (CAH) Q3 earnings report preview: what to look for
Leans bullishNov 3Elevance Health stock: Wells Fargo lifts target as Medicaid trends improve
BullishNov 3
